Filter News
Area of Research
- (-) Computational Biology (2)
- (-) Functional Materials for Energy (1)
- (-) Materials Under Extremes (1)
- Advanced Manufacturing (7)
- Biology and Environment (47)
- Building Technologies (1)
- Clean Energy (142)
- Climate and Environmental Systems (2)
- Computational Engineering (3)
- Computer Science (17)
- Electricity and Smart Grid (3)
- Fusion and Fission (9)
- Fusion Energy (4)
- Isotope Development and Production (1)
- Isotopes (2)
- Materials (102)
- Materials Characterization (1)
- Materials for Computing (21)
- Mathematics (1)
- National Security (39)
- Neutron Science (40)
- Nuclear Science and Technology (5)
- Quantum information Science (6)
- Sensors and Controls (1)
- Supercomputing (131)
- Transportation Systems (2)
News Topics
- (-) Artificial Intelligence (2)
- (-) Computer Science (1)
- (-) Grid (1)
- (-) Machine Learning (1)
- (-) Materials Science (2)
- (-) Summit (1)
- Biology (2)
- Biomedical (2)
- Buildings (1)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (2)
- Environment (1)
- Frontier (1)
- High-Performance Computing (3)
- Materials (3)
- Neutron Science (1)
- Simulation (1)
- Sustainable Energy (1)
Media Contacts
Anne Campbell, an R&D associate in ORNL’s Materials Science and Technology Division since 2016, has been selected as an associate editor of the Journal of Nuclear Materials.
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.